Enhancing pharmacosurveillance with systematic collection of treatment indication in electronic prescribing: A Validation study in Canada

Drug Safety

Volumn 33, Issue 7, 2010, Pages 559-567

  Eguale, Tewodros ^a   Winslade, Nancy ^a   Hanley, James A ^a   Buckeridge, David L ^a   Tamblyn, Robyn ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

E prescribing; Postmarketing surveillance; Prescribing.

Indexed keywords

AMFEBUTAMONE; AMIODARONE; AMITRIPTYLINE; ATENOLOL; CITALOPRAM; CLONAZEPAM; DESIPRAMINE; GABAPENTIN; HYDROXYUREA; NORTRIPTYLINE; PAROXETINE; PROPRANOLOL; QUETIAPINE; RISPERIDONE; TIOTROPIUM BROMIDE;

ADULT; ALCOHOLISM; ANGINA PECTORIS; ANXIETY DISORDER; ARTICLE; ASTHMA; ATTENTION DEFICIT DISORDER; CANADA; CHRONIC PAIN; DEPRESSION; DIABETES MELLITUS; DRUG SURVEILLANCE PROGRAM; ELECTRONIC PRESCRIBING; FEMALE; GASTROESOPHAGEAL REFLUX; GENERALIZED ANXIETY DISORDER; GOLD STANDARD; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; INFLAMMATION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; MIGRAINE; NEUROPATHIC PAIN; OBSESSIVE COMPULSIVE DISORDER; OFF LABEL DRUG USE; OSTEOPOROSIS; PAIN; POSTTRAUMATIC STRESS DISORDER; PREDICTION; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTLESS LEGS SYNDROME; SENSITIVITY AND SPECIFICITY; THROMBOCYTHEMIA; TREATMENT INDICATION; VALIDATION STUDY; VALIDITY; ELECTRONIC MEDICAL RECORD; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; STANDARDS; TRENDS;

DRUG PRESCRIPTIONS; ELECTRONIC PRESCRIBING; FEMALE; HUMANS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; OFF-LABEL USE; PROSPECTIVE STUDIES; QUEBEC;

EID: 77953565978     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11534580-000000000-00000     Document Type: Article

References (25)

1. Wiholm BE, Olsson S, Moore N, et al. Spontaneous re-porting systems outside the US. In: Strom BL, editor. Pharmacoepidemiology. 3rd ed. Chichester: Wiley, 2000: 175-192
2. Kennedy DL, Goldman SA, Lillie RB. Spontaneous re-porting systems in the US. In: Strom BL, editor. Pharma-coepidemiology. 3rd ed. Chichester: Wiley, 2000: 151-174
3. Mittmann N, Knowles SR, Gomez M, et al. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004; 27 (7): 477-487
4. Hochberg AM, Pearson RK, O'Hara DJ, et al. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System. Drug Saf 2009; 32 (2): 137-146
5. Currie CJ, MacDonald TM. Use of routine healthcare data in safe and cost-effective drug use. Drug Saf 2000 Feb; 22 (2): 97-102
6. Avorn J. Drug warnings that can cause fits: communicating risks in a data-poor environment. N Engl J Med 2008 Sep 4; 359 (10): 991-994
7. Ornum MV. E-prescribing safely. In: Van Ornum M, editor. Electronic prescribing: a safety and implementation guide. Toronto (ON): Jones and Bartlett Publishers, 2009
8. Millonig MK, Jackson TL, Ellis WM. Improving med-ication use through pharmacists' access to patient-specific health care information. J Am Pharm Assoc (Wash) 2002 Jul; 42 (4): 638-645
9. Tamblyn R, Huang A, Kawasumi Y, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc 2006 Mar 1; 13 (2): 148-159
10. Wang CJ, Marken RS, Meili RC, et al. Functional char-acteristics of commercial ambulatory electronic prescribing systems: a field study. J Am Med Inform Assoc 2005 May; 12 (3): 346-356
11. Eguale T, Tamblyn R, Winslade N, et al. Detection of adverse drug events and other treatment outcomes using an electronic prescribing system. Drug Saf 2008; 31 (11): 1005-1016
12. Vigilance Sante [online]. Available from URL: http://www.vigilance.ca/en/ index.html [Accessed 2009 Dec 12]
13. Health Canada. Health Canada drug product database [online]. Available from URL: http://webprod.hc-sc.gc.ca/dpd-bdpp/index-eng.jsp [Accessed 2009 Jul 7]
14. Rethans JJ, Martin E, Metsemakers J. To what extent do clinical notes by general practitioners reflect actual medical performance? A study using simulated patients. Br J Gen Pract 1994 Apr; 44 (381): 153-156
15. Whitelaw FG, Nevin SL, Milne RM, et al. Completeness and accuracy of morbidity and repeat prescribing records held on general practice computers in Scotland. Br J Gen Pract 1996 Mar; 46 (404): 181-186
16. Hogan WR, Wagner MM. Accuracy of data in computer-based patient records. J Am Med Inform Assoc 1997 Sep; 4 (5): 342-355
17. Thiru K, Hassey A, Sullivan F. Systematic review of scope and quality of electronic patient record data in primary care. BMJ 2003 May 17; 326 (7398): 1070-1072
18. Jordan K, Porcheret M, Croft P. Quality of mor-bidity coding in general practice computerized medical records: a systematic review. Fam Pract 2004 Aug; 21 (4): 396-412
19. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: Wiley, 1981
20. Strom BL, Melmon KL, Miettinen OS. Post-marketing studies of drug efficacy: why? Am J Med 1985 Mar; 78 (3): 475-480
21. Radley DC, Finkelstein SN, Stafford RS. Off-label pre-scribing among office-based physicians. Arch Intern Med 2006 May 8; 166 (9): 1021-1026
22. ESI Canada. Therapy class ranking (top 100 ranked by total claim cost): prescriptions filled from 01/2005 through 12/2005 compared to 01/2006 through 12/2006, Quebec [online]. Available from URL: http://www.esi-canada.com/aboutus/ news/health-newsflashes/master-rankings-top100- 2006-Quebec-updated.pdf [Accessed 2009 Oct 6]
23. Health Canada. Government of Canada supports electronic health record system that will save time and lives [online]. Available from URL: http://www.hc-sc.gc. ca/ahc-asc/media/nr-cp/-2009/2009-14-eng.php [Accessed 2009 Jul 8]
24. Bristol N. Obama allocates funds for health-care priorities. Lancet 2009 Mar 14; 373 (9667): 881-882
25. ESI Canada. Optimizing the value of health benefits: phar-macy claims: drug claim adjudication [online]. Available from URL: http://esi-canada.com/ clients/pharmacyclaims/[Accessed 2009 Jan 12]